It is currently Thu Jan 19, 2017 9:50 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

NABILONE - Have you tried it for pain relief?

My older brother has chronic back pain (does not have MS) and is using this drug with some success. I have been doing research and it appears some with MS pain do well on it. As there can be some serious side effects (like most prescription drugs) and it can be habit forming, I am hesitant but considering trying it to see if I experience any pain relief. Just wondering if you have tried it ...
Read more : NABILONE - Have you tried it for pain relief? | Views : 1120 | Replies : 0


Hi I just read about a medication named lemtrada by the Genzyme company. It sounds better than some I was wondering if anyone is on it.

Read more : Lemtrada | Views : 1324 | Replies : 2

Starts a dendritic cell trial adapted to MS

The Spanish Agency for Medicines and Health Products (AEMPS) has approved the first clinical trial of a specific antigen therapy based on dendritic cells adapted for patients with MS and NMO, (also called Devic's disease).

This research, which will be led by Pablo Villoslada and Daniel Benitez from the Clinic Hospital of Barcelona, is driven by the Grupo de Afectados de Esclerosis Múltiple (GAEM), and has the support of the Obra Social La Caixa.

The ...
Read more : Starts a dendritic cell trial adapted to MS | Views : 1687 | Replies : 0

MediciNova announces update on phase 2b trial

MediciNova has announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (PMS) has finished the randomisation of 255 patients, exceeding the initial goal of 250 patients........ Read More -
Read more : MediciNova announces update on phase 2b trial | Views : 1549 | Replies : 0

Metrics for evaluating therapies

MS patients try a long list of things to slow or reverse the march of our disease. How do we know what's working and what isn't? EDSS is a crude metric that measures changes over years - but many don't have the patience to continue with things that may or may not have an impact.

It seems to me that more sensitive metrics may be possible if we accept that metrics have to be individualized ...
Read more : Metrics for evaluating therapies | Views : 1489 | Replies : 0


HI Friends a common drug used for treating athlete's foot and another for alleviating eczema may be useful therapies for ms believe
read more from
Read more : RE ATHLETE'S FOOT DRUG MAY BE MS THERAPY | Views : 1391 | Replies : 0

New drug could reverse MS damage

A new experimental drug, anti-LINGO-1, has been found to repair myelin and so radically improving nerve signalling, reports The Daily Telegraph.

The scientists studied patients who had optic neuritis – damage of the optic nerve.

The results showed 53 per cent of people on the drug saw their nerve signalling restored to normal or nearly normal while on average most saw signalling between the retina and the brain improve by 41 per cent..... Read More ...
Read more : New drug could reverse MS damage | Views : 1774 | Replies : 0


Login  •  Register


Total posts 235721 • Total topics 25500 • Total members 16782

Contact us | Terms of Service